Osteogenesis imperfecta (OI) is a genetic disease that occurs in humans and animals. Individuals with OI exhibit signs of extreme bone fragility and osteopenia with frequent fractures and perinatal lethality in severe cases. In this study, we report the clinical diagnosis of OI in a dog and the use of targeted next-generation sequencing to identify a candidate autosomal dominant mutation in the COL1A2 gene. A 5-month-old male Chow Chow was examined with a fractured left humerus and resolving, bilateral femoral fractures. Radiographs revealed generalized osteopenia and bilateral humeral, radial, and femoral fractures. Targeted next-generation sequencing of genes associated with OI in humans (COL1A1, COL1A2, LEPRE1, SERPINH1, and CRTAP) revealed a G>A heterozygous mutation in the splice donor site of exon 18 of the COL1A2 gene (c.936 + 1G>A). The splice donor mutation was not detected among 91 control dogs representing 21 breeds. A comparative analysis of exon 18 and the exon-intron junction further showed that the mutated splice donor site is conserved among vertebrates. Altogether, these findings reveal a candidate autosomal splice donor site mutation causing OI in an individual Chow Chow.
Osteogenesis imperfecta (OI), or 'brittle bone disease', is an inherited disorder characterized by diffuse osteopenia and extreme bone fragility resulting in increased incidence of pathological fractures (Steiner et al. 1993) . It is the most frequently observed connective tissue disorder in humans with 9 clinical classifications (OI types I-IX) based on genetic mutations, mode of inheritance, and phenotype (Van Dijk et al. 2010; Michou and Brown 2011) . Patients with this condition have extremely brittle bones that fracture easily with severe cases resulting in stillbirth or perinatal death (Steiner et al. 1993; McAllion and Paterson 1996) . Joint laxity, blue sclerae, dwarfism, fragile teeth (dentinogenesis imperfecta), and skeletal deformities, including bulbous metaphyses, Wormian bones, and kyphoscoliosis, may also occur (Sillence et al. 1993; Plotkin 2004; Semler et al. 2010) . Histologically, bones contain persistent primary spongiosa, lack secondary spongiosa, and exhibit marked cortical hypoplasia (Steiner et al. 1993) .
In humans, the most common types of OI, accounting for over 90% of cases, are types I-IV, and these types are typically the result of autosomal dominant missense or frameshift mutations in the genes that encode collagen type I, alpha-1 (COL1A1) and collagen type I, alpha-2 (COL1A2) (Sykes et al. 1986; Sykes et al. 1990; Willing et al. 1992; Wenstrup et al. 1993) . Recently, mutations in the cartilage-associated protein (CRTAP) and leucine proline-enriched proteoglycan-1 (LEPRE1) genes have been implicated in severe autosomal recessive forms of human OI, types VII and VIII, respectively (Baldridge et al. 2008) . Splice site mutations are the second most common mutation causing OI in humans, representing approximately 20% of the mutations associated with the condition (Kuivaniemi et al. 1997; Marini et al. 2007) .
In dogs, OI most closely resembles the more common human OI types I-IV and has been reported in Golden Retriever, Collie, Poodle, Beagle, Norwegian Elkhound, Dachshund, and Bedlington Terrier, although mutations have only been identified in the Beagle, Golden Retriever, and Dachshund breeds (Campbell et al. 1997; Campbell et al. 2000; Campbell et al. 2001; Seeliger et al. 2003; Drögemüller et al. 2009; Haase et al. 2016 ). Canine OI is similarly associated with autosomal dominant mutations in the COL1A1 and COL1A2 genes and an autosomal recessive mutation in the serpin peptidase inhibitor, clade H member 1 (SERPINH1) gene, which is involved in collagen maturation (Campbell et al. 2000; Campbell et al. 2001; Drögemüller et al. 2009 ). There are currently no reports in the scientific literature of OI in the Chow Chow breed.
Although genetically engineered mouse models of OI are available, the clinical signs displayed by these mouse models often fail to resemble those of their human counterparts (Kamoun-Goldrat and Le Merrer 2007), thus given its size and other factors, the dog is thought to be, perhaps, an ideal model for human OI (Campbell et al. 2000; Campbell et al. 2001; Drögemüller et al. 2009 ). In this study, targeted next-generation sequencing was used to identify a candidate autosomal dominant mutation in the exon 18 splice donor site of the COL1A2 gene in a single Chow Chow clinically diagnosed with OI.
Materials and Methods

DNA Samples
Skin and bone samples were collected as part of the routine necropsy at the Texas A&M College of Veterinary Medicine and Biomedical Sciences Veterinary Medical Teaching Hospital. Genomic DNA was isolated from the postmortem skin sample of the Chow Chow using a standard phenol-chloroform extraction including 2 phenol-chloroform-isoamyl steps, followed by rinses with chloroform, isopropanol, and 70% ethanol. The DNA sample was reconstituted in Qiagen EB buffer (Qiagen Sciences, Germantown, MD). Genomic DNA was isolated from peripheral blood samples of control dogs (n = 91) at the University of California Davis, William R. Pritchard Veterinary Medical Teaching Hospital. All dogs were handled in accordance with good animal practice as defined by the relevant national and/ or local animal welfare bodies, and all animal work was approved by the Institutional Animal Care and Use Committee-approved protocol for Animal Care and Use #15356. Genomic DNA was isolated using the QiaAmp DNA Blood Mini Kit (Qiagen Sciences).
Targeted Sequencing
A 244 000-oligonucleotide capture microarray (SureSelect) was developed using Agilent's eArray design software. The genomic sequence of the COL1A1, COL1A2, CRTAP, LEPRE1, and SERPINH1 (canFam2) was densely tiled by overlapping oligonucleotides with a spacing of 1 base-pair (bp) across all 5 genes. Nine replicates of each oligonucleotide were printed onto the microarray. Genomic DNA from the Chow Chow was sonicated by pulsing 3× for 15 s/pulse at 14% using a Sonic Dismembrator 500 (Fisher Scientific, Pittsburg, PA) and purified with an Invitrogen PureLink PCR Kit (Invitrogen, Carlsbad, CA). The DNA was blunt endrepaired, adenylated, and ligated with paired-end adaptors according to the manufacturer's protocol (Illumina, San Diego, CA). The prepared library was resolved on a 2% low range agarose gel and a 2-mm section of DNA with an insert size of 250 bp was extracted from the gel (Qiagen Sciences, Germantown, MD). The library was then enriched according to the manufacturer's protocol with 12 independent reactions (Illumina). The reactions were pooled and purified using an Invitrogen PureLink PCR Kit (Invitrogen, Carlsbad, CA). The prepared library was combined with forward and reverse blocking oligonucleotides (the enrichment primers), along with Cot-1 DNA, Agilent 10× Blocking agent, and Agilent 2× Hi-RPM hybridization buffer. The mixture was applied to the capture microarray and hybridized at 65 °C for 65 h. The microarray was washed in Agilent wash buffers and dried. Next, nuclease-free water was added to the microarray, and then a slide gasket was applied and heated at 95 °C for 10 min. The eluted DNA was collected from the slide and concentrated to a volume of 50 µL. The library was then enriched following the manufacturer's recommended protocol (Illumina). The size and concentration of the sequencing library was determined by polymerase chain reaction (PCR), visualization of amplicons by polyacrylamide gel electrophoresis and by an Agilent 2100 Bioanalyzer DNA kit (Agilent Technologies, San Diego, CA). Seventy-five bp single-end massively parallel sequencing was performed at the AgriLife Genomics and Bioinformatics Core at Texas A&M University.
Sequence Alignment
Sequences were trimmed in CLC genomics using the following parameters: ambiguous limit = 2; ambiguous trim = yes; quality limit = 0.1; quality trim = yes; remove 3′ nucleotide = no; remove 5′ nucleotide = no. Trimmed sequences were mapped to the canFam2 reference assembly using CLC Genomics Workbench's Reference Mapping function with the following parameters: similarity score = 0.8 and length fraction = 0.5.
Sequence Analysis
Single-nucleotide variants (SNVs) were identified in uniquely mapped reads using CLC Genomics Workbench's SNP detection function with the following parameters: minimum coverage = 5; minimum central base quality = 30; average base quality over a window length of 11 nucleotides = 15; and minimum allele frequency = 35%. Insertion/deletion polymorphisms (INDELs) were identified using the deletion and insertion polymorphism (DIP) function in CLC Genomics Workbench with the following parameters: minimum coverage = 5; minimum allele frequency = 35%; and maximum expected variation = 2.
Variant Annotation and Analysis
Genetic variants were annotated using the ANNOVAR program . The Ensembl annotations for all 5 genes were used by ANNOVAR to create an mRNA database to determine the effect of missense variants. The positions and the amino acid changes of all variants were annotated using ANNOVAR. Splice site variants were investigated using the Splice Site Prediction tool (Reese et al. 1997 ; http://www.fruitfly.org/seq_tools/splice.html).
Confirmation of Candidate Variants
Sanger sequencing was used to confirm the candidate variants in the affected animal. PCR primers were designed using Primer3Plus (Untergasser et al. 2007) . PCR amplicons were purified using the Invitrogen PCR purification kit (Invitrogen), and Sanger sequenced was performed at the Texas A&M University DNA Core Technologies Lab. Sanger sequences were aligned using the ClustalW alignment tool (http://www.ebi.ac.uk/Tools/msa/ clustalw2/). Candidate variants were examined in control dogs by either Sanger sequencing (n = 1), a custom tetra-primer ARMS PCR reaction (n = 91) (Ye et al. 2001) , or the Dog Genome SNP Database (DoGSD; http://dogsd.big.ac.cn/), which represents both domesticated dogs (n = 69) and gray wolves (n = 8) (Bai et al. 2015) .
All primers used for sequencing and genotyping are listed in Supplementary Table 1 .
Results
Diagnosis of OI in the Affected Chow Chow
A 5-month-old male Chow Chow presented for acute lameness of the left front leg. The main presenting sign was due to an acute, complete, oblique, closed, mid-diaphyseal fracture of the left humerus. A healing fracture of the distal left ulna and generalized osteopenia was also evident in a clinical radiograph taken at the time of the initial examination ( Figure 1A ). Complete examination found multiple long bone fractures of different ages and stages of repair that include bilateral fractures of the distal humerus, femur, and ulna. Based on the age of the dog, the presence of multiple fractures, and general osteopenia, a clinical diagnosis of OI was made. Because of poor prognosis, euthanasia was performed. A female littermate of this dog was similarly affected, but this dog and the parents were not available for examination or for the isolation of familial genomic DNA.
A necropsy examination found that all long bones were brittle and had thin cortices. Although the fracture in the left humerus was acute and located in the diaphysis, the other fractures were centered in the metaphysis. A focal increase in bone diameter at the fracture site was associated with callus formation (Figure 1B,C) . Histologically, the metaphyseal spongiosa of all long bones had retained primary trabecular bone systems due to failure of bone remodeling and conversion of primary trabecular bone to secondary trabecular bone, which is a diagnostic feature of OI. Bone density in both the epiphyseal and metaphyseal spongiosa was abnormally low ( Figure 1D-G) , predisposing to metaphyseal fracture ( Figure 1D ). Metaphyseal spongiosa was formed of delicate bony trabecula that easily fractured ( Figure 1H,I ). These thin trabecular bones, formed primarily of woven bone and central cartilage remnants, had not been removed by the normal bone remodeling process. Osteoporotic cortices were also formed primarily of woven bone deposited by an inactive periosteum and by the failure of osteoblasts to apply appositional deposits of lamellar bone to the newly formed periosteal bone surfaces ( Figure 1J ,K).
Targeted Next-Generation Sequencing of Candidate OI Genes
Because familial DNA samples were not available for a linkage study, targeted next-generation sequencing of genes associated with OI in humans was performed on the affected Chow Chow (hereafter referred to as Chow). The sequenced regions involved the coding and noncoding regions of the COL1A1, COL1A2, CRTAP, LEPRE1, and SERPINH1 genes. An ultra-deep sequence (1605X) of each targeted region was generated with 100% of the exons sequenced (Table 1) Table 3 ). None of the variants were known to be associated with OI in humans or animals.
The LEPRE1 NS-SNV (c.778G>C) and INDEL (c.774_775insC) were present in 10 control dogs representing 10 different breeds. The LEPRE1 INDEL was also conserved among mammalian species, suggesting that this insertion was, perhaps, either present in the Boxer used for the reference genome assembly or a sequencing artifact in the reference assembly. The sequence of the INDEL and flanking regions was deposited to NCBI (Accession No. KC808166). Likewise, the SERPINH1 NS-SNV (c.47T>C) variant was present in a control German Shepherd (c. [47T>C];[47T>C] ). As such, the LEPRE1 and SERPINH1 variants were excluded as causative mutations.
The heterozygous COL1A2 SS-SNV (c.936 + 1G>A) was confirmed in the targeted sequencing data and by Sanger sequencing (Figure 2A-C) ; however, it was not detected among 160 control dogs nor in 8 gray wolves (Supplementary Figure 1 and Supplementary  Table 2 ). Comparative genomic analysis of the COL1A2 exon 18 exon-intron junction further showed that splice donor site is conserved among vertebrate animals, including Zebrafish and Lamprey ( Figure 2D ). Bioinformatic analysis of the SNV predicted aberrant splicing between exons 17 and 19, leading to an in-frame deletion of exon 18.
Discussion
In this study, we clinically diagnosed a Chow with OI and then used targeted next-generation sequencing of candidate genes to identify the causative mutation. Our results revealed a heterozygous variant in the splice donor site of exon 18 of the COL1A2 gene. The splice donor site is highly conserved among vertebrate animals and was not detected in a cohort of control dogs representing diverse breeds.
Targeted sequencing of genes associated with OI in humans (COL1A1, COL1A2, LEPRE1, and CRTAP) (Bodian et al. 2009 ) and dogs (COL1A1, COL1A2, and SERPINH1) (Campbell et al. 2000; Campbell et al. 2001; Drögemüller et al. 2009 ) was chosen for this study because no familial DNA samples were available to perform a linkage study. Because of this, we were unable to determine the inheritance pattern or to predict a candidate gene/mutation for analysis. In cases where a linkage study is not feasible, targeted sequencing of candidate genes, exomes, and genomes has proven to be a valuable approach for identifying disease-causing mutations (Choi et al. 2009; Irizarry et al. 2009; Gilissen et al. 2010; Hoischen et al. 2010; Johnson, Mandrioli et al. 2010; Lalonde et al. 2010; Lupski et al. 2010; Musunuru et al. 2010; Pierce et al. 2010; Arboleda et al. 2012) , particularly diseases without a clear pattern of inheritance, such as de novo mutations (Iossifov et al. 2012; O'Roak et al. 2012; Sanders et al. 2012) . In fact, this strategy has been successfully used to identify a candidate causative mutation in an individual human patient with OI (Becker et al. 2011) . We hypothesized that targeted sequencing of the coding and noncoding regions of the most common genes causing OI in humans and dogs would yield the greatest chance for identifying the mutation in the affected Chow. The COL1A2 gene encodes the pro-alpha2 chain of type I collagen that when combined with 2 collagen alpha-1 chains results in the formation of the triple helical structure of fibril-forming collagen, which is found in connective tissues and is abundant in bone, cornea, dermis, and tendons. In humans, approximately 85% of cases of OI are caused by mutations in the COL1A1 and COL1A2 genes. Mutations in the COL1A2 gene are typically nonlethal (80%) and lead to Ehlers-Danlos syndrome type VIIB (OMIM#130060) and OI types II (OMIM#166210), III (OMIM#259420), and IV (OMIM#166220), which present with similar phenotypes as those observed in the affected Chow. Splice site mutations make up 20% of helical mutations in human OI patients, with several splice mutations in COL1A2 causing OI (Weil et al. 1989; Ganguly et al. 1991; Vasan et al. 1991; Chiodo et al. 1992; Nicholls et al. 1992; Wenstrup et al. 1993; Nicholls et al. 1996; Byers et al. 1997; Zolezzi et al. 1997) . Interestingly, there are reportedly 4 times as many more independent mutations at splice donor sites than splice acceptor sites in the COL1A2 gene (Marini et al. 2007 ). In dogs, mutations in the COL1A1 and COL1A2 genes have been shown to cause autosomal dominant forms of OI (Campbell et al. 2000 (Campbell et al. , 2001 . Despite numerous efforts, the poor quality of the RNA retrieved from the bone of the affected Chow prevented us from examining the effect of the candidate variant on the splicing and expression of COL1A2, which is a major limitation of the study. Nevertheless, given the conservation of the splice donor site among vertebrates and the known role of splice donor mutations in OI and other monogenetic disorders, it seems likely that the COL1A2+1G>A heterozygous variant is indeed the causative mutation in the affected dog. Clearly, future studies are needed to demonstrate the role of this variant on COL1A2 expression and function as well as the incidence of the variant in a large cohort of control and affected animals, but this finding provides a candidate mutation to examine in other dogs presenting with similar phenotypes.
In conclusion, we clinically diagnosed a Chow Chow with OI and identified a novel splice donor site variant in the COL1A2 gene as a candidate causative mutation. Given the known mutations causing human OI in exon 18, our findings may someday lead to the development of a spontaneous canine model for human OI. Furthermore, as the cost of next-generation sequencing continues to decrease, targeted sequencing may very well become an affordable and complementary method to the clinical diagnosis of disease in dogs and an alternative approach to conventional linkage and association studies.
Supplementary Material
Supplementary data are available at Journal of Heredity online.
